Login

How to Break Into Venture Capital (VC)|Lindy Morris Fishburne,Managing Partner,Breakout Ventures 00:10:00

Share On Facebook Share On Twitter

Invests at the intersection of technology and biology.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The company specializing in cryptoassets|Linda Xie,Co-Founder and Managing Director,Scalar Capital
00:10:00
We are a leading provider of active asset management, advisory and wealth management services. Recognised as a leader in sustainability. Few investment managers can match the combination of capabilities and global reach that we offer | Peter Harrison,Grou
00:10:00
We steward capital and companies to help the world flourish|JASON ILLIAN,CEO,Highmount Capital LLC
00:10:00
The system is the star The more stars we have in our system the brighter the system burns|Justin Ishbia,Managing Partner,Shore Points Capital
00:10:00
Unpacking the Impact of ESG on Modern Investment Strategies | Jennifer Luzzatto, President, Summit Financial Partners, Inc.
00:10:00
From Student Entrepreneurship Advocate to Leading Deep-Tech VC | Peter Hébert, Co-founder, Lux Capital.
00:10:00
Wall Street Connected: Callon Petroleum | Joseph C Gatto Jr, CEO, Callon Petroleum CoCPE:NYQ
00:10:00
Vow ASA Launches Vow Green Metals: A Step Toward Sustainable Metallurgy | Henrik Badin, CEO, Vow ASA.
00:10:00
Our mission is to be a world-class, industry leading organization that creates long term value for our investors and sustains results across market cycles.|Cory Olson,Chief Operating Officer,Rialto Capital, FS Credit Real Estate Income Trust, Inc.
00:10:00
Kjartan Rist on Driving Sustainable Growth Through Balanced Investment Strategies | Kjartan Rist, Founder, Concentric
00:10:00
Joining O’Melveny: Achieve More | Allen Burton - Partner, O'Melveny & Myers LLP
00:10:00
Bridget Sora on the Impact of ACP Conferences and Overcoming Impostor Syndrome

© 2017 - Neuhu+